AAO News
The latest clinical breakthroughs, practice management updates, and national advocacy alerts directly from the American Academy of Ophthalmology.
Ranibizumab catches up with aflibercept at 2 years
The early advantage aflibercept showed in treating patients with DME narrowed after 2 years of treatment, according to follow-up data from the DRCR.net Protocol T study.
Powered by Suchmaschinenoptimierung
Our Industry Partners
Empowering Excellence in Ophthalmology
We extend our deepest gratitude to our Platinum, Gold, and Silver partners. Your generous support fuels our mission to advance medical education, advocate for patient safety, and foster breakthrough innovations across West Virginia.
West Virginia Academy of Eye Physicians and Surgeons — advancing quality eye care through education, advocacy, and community awareness.
About
Resources
Advocacy